The partnership will help develop standards for data transfer to eliminate manual steps used in clinical trials.
Pharmaceutical giant Sanofi and health care technology company Flatiron Health, known for its innovative oncology products, on Monday announced a partnership to develop standards for pulling data from electronic health records (EHRs) for use in point-of-care systems in clinical trials.
Since the development of EHR systems, clinicians, researchers and regulators have criticized the hurdles to extracting data in useful formats, for everything from reporting quality metrics to drug development. Of particular concern is the need for electronic data capture (EDC) in clinical trials, to replace the time-consuming, error-prone tasks needed for data transfer at trial sites.
Enter the collaboration between Sanofi and Flatiron, which centers on Flatiron’s product, Flatiron Clinical Pipe. Described in a statement as “one of the industry’s first scalable EHR-to-EDC technologies,” it was recently launched in a study by the 2 companies and transferred more than 50% of the study data from the EHR to the EDC.
Time not spent on manual data entry and resolution will allow clinicians at trial sites to spend more time on patient care, and use of an EHR-to-EDC technology could make bringing trials to the community setting less daunting for smaller practices. However, company officials said in the statement that Flatiron Clinical Pipe is equally appropriate for the academic setting.
Having reached the 50% mark in data transfer, the companies said their collaboration will explore additional types of data that can be automatically transferred, allowing trial sites and Sanofi’s investigators to achieve greater levels of efficiency and reduce errors.
Flatiron, already a leading provider of technology for community oncology practices, sees this step as a “natural progression,” Alex Deyle, general manager, Clinical Research, Flatiron Health, said in the statement.
“With the FDA’s guidance on interoperable technology that allows electronic transmission of relevant EHR data to the EDC system, we knew we had an opportunity with Flatiron Clinical Pipe to unlock the potential of data captured in the EHR, reduce the burden of clinical trials and accelerate research timelines,” Deyle said.
Reference
Flatiron Health embarks on strategic collaboration with Sanofi to make clinical trials more efficient by streamlining data acquisition at the point of care. News release. Flatiron Health. May 1, 2023. Accessed May 2, 2023. https://bit.ly/42iKdjy
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
OS Better With Belantamab Mafodotin Triplet vs Daratumumab in R/R MM
November 19th 2024The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R MM).
Read More